van Diepen Sean, Graham Michelle M, Nagendran Jayan, Norris Colleen M
Divisions of Critical Care and Cardiology, 2C2 WMC University of Alberta Hospital, 8440-112 St, Edmonton, AB, Canada, T6G 2B7.
Division of Cardiology, 2C2 WMC University of Alberta Hospital, 8440-112 St, Edmonton, AB, Canada, T6G 2B7.
Crit Care. 2014 Nov 19;18(6):651. doi: 10.1186/s13054-014-0651-5.
In medical and surgical intensive care units, clinical risk prediction models for readmission have been developed; however, studies reporting the risks for cardiovascular intensive care unit (CVICU) readmission have been methodologically limited by small numbers of outcomes, unreported measures of calibration or discrimination, or a lack of information spanning the entire perioperative period. The purpose of this study was to derive and validate a clinical prediction model for CVICU readmission in cardiac surgical patients.
A total of 10,799 patients more than or equal to 18 years in the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry who underwent cardiac surgery (coronary artery bypass or valvular surgery) between 2004 and 2012 and were discharged alive from the first CVICU admission were included. The full cohort was used to derive the clinical prediction model and the model was internally validated with bootstrapping. Discrimination and calibration were assessed using the AUC c index and the Hosmer-Lemeshow tests, respectively.
A total of 479 (4.4%) patients required CVICU readmission. The mean CVICU length of stay (19.9 versus 3.3 days, P <0.001) and in-hospital mortality (14.4% versus 2.2%, P <0.001) were higher among patients readmitted to the CVICU. In the derivation cohort, a total of three preoperative (age ≥ 70, ejection fraction, chronic lung disease), two intraoperative (single valve repair or replacement plus non-CABG surgery, multivalve repair or replacement), and seven postoperative variables (cardiac arrest, pneumonia, pleural effusion, deep sternal wound infection, leg graft harvest site infection, gastrointestinal bleed, neurologic complications) were independently associated with CVICU readmission. The clinical prediction model had robust discrimination and calibration in the derivation cohort (AUC c index = 0.799; Hosmer-Lemeshow P = 0.192). The validation point estimates and confidence intervals were similar to derivation model.
In a large population-based dataset incorporating a comprehensive set of perioperative variables, we have derived a clinical prediction model with excellent discrimination and calibration. This model identifies opportunities for targeted therapeutic interventions aimed at reducing CVICU readmissions in high-risk patients.
在医疗和外科重症监护病房,已经开发出了再入院的临床风险预测模型;然而,报告心血管重症监护病房(CVICU)再入院风险的研究在方法上受到结果数量少、未报告校准或区分度测量方法,或缺乏整个围手术期信息的限制。本研究的目的是推导并验证心脏手术患者CVICU再入院的临床预测模型。
纳入了阿尔伯塔省冠心病结局评估项目(APPROACH)登记处10799例年龄大于或等于18岁的患者,这些患者在2004年至2012年间接受了心脏手术(冠状动脉搭桥术或瓣膜手术),并从首次CVICU入院中存活出院。整个队列用于推导临床预测模型,并通过自举法进行内部验证。分别使用AUC c指数和Hosmer-Lemeshow检验评估区分度和校准情况。
共有479例(4.4%)患者需要CVICU再入院。CVICU再入院患者的平均住院时间(19.9天对3.3天,P<0.001)和院内死亡率(14.4%对2.2%,P<0.001)更高。在推导队列中,共有三个术前变量(年龄≥70岁、射血分数、慢性肺病)、两个术中变量(单瓣膜修复或置换加非冠状动脉搭桥手术、多瓣膜修复或置换)和七个术后变量(心脏骤停、肺炎、胸腔积液、深部胸骨伤口感染、腿部移植物采集部位感染、胃肠道出血、神经系统并发症)与CVICU再入院独立相关。临床预测模型在推导队列中具有较强的区分度和校准度(AUC c指数=0.799;Hosmer-Lemeshow P=0.192)。验证点估计值和置信区间与推导模型相似。
在一个包含全面围手术期变量的大型基于人群的数据集中,我们推导了一个具有出色区分度和校准度的临床预测模型。该模型确定了针对高风险患者进行有针对性治疗干预以减少CVICU再入院的机会。